Pharmaceuticals in raw and treated water from drinking water treatment plants nationwide: Insights into their sources and exposure risk assessment
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- Water Research X24 · 2024
- 피인용
- Web of Science 51Scopus 62
- FWCI (Scopus)
- 5
- JCR IF
- JCR 2023 7.2
- ISSN
- 2589-9147
저자
- 킴벌리 에톰비 무암보제1저자Pusan Natl Univ, Dept Civil & Environm Engn, Busan 46241, South Korea
- 김민경Pusan Natl Univ, Dept Civil & Environm Engn, Busan 46241, South Korea
- 김다혜Pusan Natl Univ, Inst Environm & Energy, Busan 46241, South Korea
- Park, SangminNatl Inst Environm Res, Dept Environm Infrastruct Res, Minist Environm, Incheon 22689, South Korea
- 오정은교신저자Pusan Natl Univ, Inst Environm & Energy, Busan 46241, South Korea
초록
Due to the large amounts of pharmaceuticals and personal care products (PPCPs) currently being consumed and released into the environment, this study provides a comprehensive analysis of pharmaceutical pollution in both raw and treated water from full-scale drinking water treatment plants nationwide. Our investigation revealed that 30 out of 37 PPCPs were present in raw water with mean concentrations ranging from 0.01–131 ng/L. The raw water sources, surface water (ND – 147 ng/L), subsurface water (ND – 123 ng/L) and reservoir sources (ND – 135 ng/L) exhibited higher mean concentration levels of pharmaceutical residues compared to groundwater sources (ND – 1.89 ng/L). Meanwhile, in treated water, 17 of the 37 analyzed PPCPs were present with carbamazepine, clarithromycin, fluconazole, telmisartan, valsartan, and cotinine being the most common (detection frequency > 40 %), and having mean concentrations of 1.22, 0.12, 3.48, 40.1, 6.36, and 3.73 ng/L, respectively. These findings highlight that, while water treatment processes are effective, there are some persistent compounds that prove challenging to fully eliminate. Using Monte Carlo simulations, risk assessment indicated that most of these compounds are likely to have negligible impact on human health, except for the antihypertensives. Telmisartan was identified as posing the highest ecological risk (RQ > 1), warranting further investigation, and monitoring. The study concludes by prioritizing specific 14 pharmaceuticals, including telmisartan, clarithromycin, lamotrigine, cotinine, lidocaine, tramadol, and others, for future monitoring to safeguard both ecological and human health.
키워드
Drinking waterEmerging contaminantsHuman riskRemovalPERSONAL CARE PRODUCTSENDOCRINE-DISRUPTING CHEMICALSCONCERN IN-SOURCEEMERGING CONCERNWASTE-WATERTAP WATERREMOVALCONTAMINANTSSURFACEPPCPS
식별자
- Scopus EID
- 2-s2.0-85203122561
- WoS UID
- 001310329600001



로그인
연구물 목록으로